
Billy Bush
Ask VT AI
View News Summary
- Novo Nordisk challenges Pfizer's acquisition of Metsera with a $6.5 billion bid, sparking a high-stakes contest for obesity and GLP-1 assets.
- Altria's Q3 earnings beat estimates, but shares fell on a weak outlook and persistent category challenges.
- Fed Chair Powell's comments on December rate cut uncertainty send markets into a mixed reaction, with Treasury yields rising and small caps falling.
20 hours

United States Politics
Discover the latest news, candidates, and key topics of US politics
Ask VT AI
View News Summary
- Novo Nordisk challenges Pfizer's acquisition of Metsera with a $6.5 billion bid, sparking a high-stakes contest for obesity and GLP-1 assets.
- Altria's Q3 earnings beat estimates, but shares fell on a weak outlook and persistent category challenges.
- Fed Chair Powell's comments on December rate cut uncertainty send markets into a mixed reaction, with Treasury yields rising and small caps falling.
20 hours

United States Politics
Discover the latest news, candidates, and key topics of US politics
Most Reported By
News from Billy Bush
News from Billy Bush
